(Q53222728)

12 May 2018

title

Comparison and validation of three measures of quality of life in patients with pulmonary hypertension. (English)

1 reference

12 May 2018

1 reference

Chua R

1

1 reference

12 May 2018

Keogh AM

series ordinal

2

1 reference

12 May 2018

Byth K

series ordinal

3

1 reference

12 May 2018

O'Loughlin A

series ordinal

4

1 reference

12 May 2018

publication date

1 November 2006

1 reference

12 May 2018

Internal Medicine Journal

published in

1 reference

12 May 2018

volume

36

1 reference

12 May 2018

issue

11

1 reference

12 May 2018

page(s)

705-710

1 reference

12 May 2018

New treatments for pulmonary arterial hypertension

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

Survival with first-line bosentan in patients with primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

Evaluation of 3 quality of life measurement tools in patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

Random-effects models for longitudinal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2006.01169.X

10.1111/J.1445-5994.2006.01169.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

17040356

1 reference

12 May 2018